Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.51 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9815726 | 0.88 | SLC6A2 (0.61) | LTA4HEPHX2HRH3ALDH1A1LMNA | |
| SCHEMBL16440938 | 0.84 | HRH3 (0.55) | LTA4HEPHX2HRH3ALDH1A1LMNA | |
| SCHEMBL27312245 | 0.84 | LTA4H (0.70) | LTA4HEPHX2LMNABCHEFFAR1 | |
| SCHEMBL16440934 | 0.84 | HRH3 (0.55) | LTA4HEPHX2HRH3ALDH1A1LMNA | |
| SCHEMBL13483788 | 0.84 | HRH3 (0.55) | LTA4HEPHX2HRH3ALDH1A1MAPK1 | |
| SCHEMBL358689 | 0.83 | CA2 (0.59) | ALDH1A1LMNACYP3A4SMN1; SMN2THRB | |
| SCHEMBL9815722 | 0.83 | HRH3 (0.54) | LTA4HEPHX2HRH3BCHEFFAR1 | |
| SCHEMBL16440940 | 0.83 | MAOB (0.63) | LTA4HEPHX2HRH3BCHE | |
| SCHEMBL16428970 | 0.83 | HRH3 (0.54) | LTA4HEPHX2HRH3CYP3A4BCHE | |
| SCHEMBL18637175 | 0.82 | RXRA (0.64) | LTA4HEPHX2HRH3LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210308660-A1 | CROSS-COUPLING REACTION CATALYST | N.E. CHEMCAT CORPORATION (JP) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210308660-A1 | CROSS-COUPLING REACTION CATALYST | RRS1, RER1, CBR1 | LTA4H 1426/4885EPHX2 537/4885HRH3 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.